当前位置: X-MOL 学术J. Cancer Res. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer
Journal of Cancer Research and Therapeutics ( IF 1.4 ) Pub Date : 2021-07-01 , DOI: 10.4103/jcrt.jcrt_214_21
Zhi-Gang Yao 1 , Bei-Bei Lv 1 , Hai-Yan Jing 1 , Wen-Jing Su 1 , Jia-Mei Li 1 , Hui Fan 1 , Miao-Qing Zhao 1 , Ye-Jun Qin 1 , Xi-Chao Sun 1
Affiliation  


Objectives: The objective of the study is to provide an efficient and practical screening strategy to distinguish a broader spectrum of Lynch syndrome (LS) and LS mimics-associated colorectal cancer (CRC), including Lynch-like syndrome (LLS), constitutional mismatch repair-deficiency, familial CRC type X (FCCTX), and polymerase proofreading-associated polyposis syndrome.
Materials and Methods: 1294 cases of CRC samples were detected mismatch repair (MMR) status using immunohistochemistry (IHC) staining, in which the cases with MLH1-deficient CRC underwent BRAF mutation analysis by IHC. Following the personal and/or family history survey, next-generation sequencing (NGS) was used to detect gene variants.
Results: 1294 CRC patients were dichotomized into tumors caused by a deficient MMR (dMMR) system and a proficient MMR (pMMR) system after MMR status analysis. 45 patients with suspected sporadic dMMR CRC were then separated from MLH1-deficient CRC though BRAF mutation status analysis by IHC. Following the personal and/or family history survey for 1294 patients, as well as germline genetic testing by NGS, 34 patients were diagnosed as LS (8 cases), SLS (13 cases), LLS ( 6 cases), FCCTX (3 cases), and sporadic CRC (4 cases).
Conclusions: Our screening strategy, which consists of clinical and molecular analyses, is expected to improve the screening efficiency and management for the LS and LS mimics.


中文翻译:

林奇综合征和林奇综合征在结直肠癌中的一种实用筛查策略


目的:本研究的目的是提供一种有效且实用的筛查策略,以区分更广泛的林奇综合征 (LS) 和 LS 模拟相关结直肠癌 (CRC),包括林奇样综合征 (LLS)、体质错配修复-缺乏,家族性CRC X型(FCCTX)和聚合酶校对相关的息肉病综合征。
材料与方法:采用免疫组织化学(IHC)染色检测1294例CRC样本的错配修复(MMR)状态,其中MLH1缺陷的CRC病例通过IHC进行BRAF突变分析。在个人和/或家族史调查之后,使用下一代测序 (NGS) 检测基因变异。
结果:1294 例 CRC 患者在 MMR 状态分析后被分为由缺陷 MMR (dMMR) 系统和精通 MMR (pMMR) 系统引起的肿瘤。然后通过 IHC 的 BRAF 突变状态分析将 45 名疑似散发性 dMMR CRC 患者与 MLH1 缺陷型 CRC 分开。经对1294例患者的个人和/或家族史调查,以及NGS生殖系基因检测,34例患者被诊断为LS(8例)、SLS(13例)、LLS(6例)、FCCTX(3例)和散发性CRC(4例)。
结论:我们的筛查策略包括临床和分子分析,有望提高 LS 和 LS 模拟物的筛查效率和管理。
更新日期:2021-07-12
down
wechat
bug